GlenRock Group

About

Portfolio · 5

Smartsen Ltd.

SmartSen has developed a smart sensor, comprised of various sensing technologies to assist doctors in accurately diagnosing medical conditions.

1 round $14.5M committed Latest: 2024

IM Cannabis

IM Cannabis is an international cannabis company focused on providing premium cannabis products to medical patients in Israel and Germany.

Led ★ 1 round $9.1M committed Latest: 2018-04

Veloryx

An integrated Homeland Security (HLS) company focused on building a unified security ecosystem by combining advanced technologies and human factors, with operational expertise.

Led ★ 2 rounds $7.5M committed Latest: 2016-02

Outbrain

A leading native advertising platform that helps publishers increase traffic and revenue by recommending personalized content.

Led ★ 3 rounds $51.0M committed Latest: 2011-12

Mobileye

A global leader in autonomous driving technology and advanced driver-assistance systems (ADAS), providing vision-based sensing and AI software for vehicles worldwide.

1 round $15.0M committed Latest: 2006-05

Investment activity

14 portfolio exits on record.

Q&A

What are GlenRock Group's most recent exits?

GlenRock Group has two recent exits: Capitalise was acquired by Kraken in August 2025, and Model9 was acquired by BMC Software in April 2023.

Which sectors does GlenRock Group primarily invest in?

GlenRock Group shows a strong concentration in Health Tech & Life Sciences, with 12 portfolio companies, and Industrial Technologies, with 5 portfolio companies.

Can you name some of GlenRock Group's portfolio companies in the Cyber Security sector?

GlenRock Group's portfolio includes CyberX, which was acquired by Microsoft in June 2020, and Cylus, a railway cybersecurity solutions provider.

What is GlenRock Group's investment focus according to their thesis?

GlenRock Group is a single-family office that focuses on Life Sciences, Advanced Technology, and Private Equity, taking an active and long-term role in their portfolio companies.

Which public exits has GlenRock Group had in recent years?

GlenRock Group has seen several public exits, including Teads, which went public on NASDAQ in July 2021 with a valuation of $1.25 billion, and Idomoo, which went public on TASE in June 2021 with a valuation of $105.83 million.

Who are the key personnel at GlenRock Group?

The key personnel at GlenRock Group include Leon Recanati, the Founder & CEO, and Asaf Iram, a Managing Partner.

Has GlenRock Group had any notable exits in the Health Tech & Life Sciences sector?

Yes, Cardiovalve was acquired by Venus Medtech for $150 million in March 2022, and LifeBond was acquired by Bard Medical for $60 million in January 2020.

What is the typical investment stage for GlenRock Group?

GlenRock Group invests across various stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.